Question 1

Is compounded semaglutide the exact same thing as Wegovy?

Accepted Answer

Compounded semaglutide and branded Wegovy both contain semaglutide as the active ingredient. Wegovy is an FDA-approved, pre-filled auto-injector manufactured by Novo Nordisk. Compounded semaglutide is prepared by licensed 503A pharmacies as a vial for subcutaneous injection. Compounded formulations are not FDA-approved as finished products and are manufactured differently from branded Wegovy.

Question 2

Why is Wegovy so much more expensive?

Accepted Answer

Wegovy's $1,349/month price reflects Novo Nordisk's patent protection, massive direct-to-consumer advertising budget, and pharmaceutical industry pricing practices. The semaglutide molecule itself is not inherently expensive. Compounded semaglutide eliminates the brand markup, proprietary device costs, and marketing overhead, passing the savings directly to patients.

Question 3

How does the dosing compare between Wegovy and compounded semaglutide?

Accepted Answer

Both follow the same evidence-based titration protocol. Wegovy uses a fixed-dose pen system (0.25mg → 0.5mg → 1.0mg → 1.7mg → 2.4mg). Compounded semaglutide offers the advantage of more flexible dosing, your FormBlends physician can prescribe precise doses tailored to your response, including intermediate doses that the branded pen system does not offer. This granularity often results in fewer side effects during titration.

Question 4

Can I switch from Wegovy to compounded semaglutide mid-treatment?

Accepted Answer

Absolutely. Your FormBlends physician will match your current Wegovy dose exactly, so there is no need to restart titration from the beginning. Most patients transition between their last Wegovy injection and their first compounded dose without any interruption in treatment or change in results.

Question 5

What about the auto-injector convenience? Isn't the pen easier?

Accepted Answer

The Wegovy auto-injector is a convenience feature, but it is not a clinical advantage. Compounded semaglutide is administered via a small insulin-style syringe, the same type that millions of diabetic patients use daily with ease. Most patients become comfortable with the process after their first self-injection. Many actually prefer the vial format because it allows for precise dose adjustments.

Question 6

Are there any clinical differences in outcomes?

Accepted Answer

The clinical outcomes are driven by the semaglutide molecule, not the brand name. Both formulations deliver semaglutide subcutaneously, where it acts on GLP-1 receptors throughout the body. Clinical trial data was generated using branded formulations. Compounded semaglutide contains semaglutide as the active ingredient. Your physician will monitor your individual response.

Wegovy vs Compounded Semaglutide: An Honest Side-by-Side

Affordable GLP-1 Therapy With Full Physician Support.

Helpful Content